Proliferation of MIELIKI a novel t(7;9) early pre-B acute lymphoblastic leukemia cell line is inhibited concomitantly by IL-4 and IL-7. 1995

N Renard, and V Duvert, and D J Matthews, and M P Pagés, and J P Magaud, and A M Manel, and D Pandrau-Garcia, and N Philippe, and J Banchereau, and S Saeland
Schering-Plough, Laboratory for Immunological Research, Dardilly, France.

The present study describes a novel cell line, MIELIKI, established from bone marrow of a pediatric patient with B lineage acute lymphoblastic leukemia (ALL) at diagnosis. The MIELIKI cell line displays an early pre-B cell phenotype (CD10+, CD19+, CD20+, CD34-, Cmu-, sIg-) with rearrangements on both Ig heavy chain and k light chain alleles, and carries an unfrequent t(7;9) chromosomal translocation identical to the freshly isolated leukemic blasts. The proliferation of MIELIKI cells was abrogated by IL-4 and by IL-7, as measured by DNA replication and viable cell recovery. The effects of IL-4 and IL-7 were mediated, respectively, through the CDw124 and CDw127 IL-4 and IL-7 receptor components. Growth inhibition by IL-4 was not mediated by soluble factors released by MIELIKI cells in response to IL-4, suggesting the existence of an intrinsic negative signaling pathway. Finally, neither IL-4 nor IL-7 were found to induce maturation of MIELIKI into cells expressing cytoplasmic or surface membrane mu chain. The present cell line should constitute a useful model of t(7;9) early pre-B ALL and allow investigation of the relationship between IL-4 and IL-7 negative signaling in leukemic B cell ontogeny.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002897 Chromosomes, Human, Pair 7 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 7
D002899 Chromosomes, Human, Pair 9 A specific pair of GROUP C CHROMSOMES of the human chromosome classification. Chromosome 9
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014178 Translocation, Genetic A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome. Chromosomal Translocation,Translocation, Chromosomal,Chromosomal Translocations,Genetic Translocation,Genetic Translocations,Translocations, Chromosomal,Translocations, Genetic
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015326 Gene Rearrangement, B-Lymphocyte, Heavy Chain Ordered rearrangement of B-lymphocyte variable gene regions of the IMMUNOGLOBULIN HEAVY CHAINS, thereby contributing to antibody diversity. It occurs during the first stage of differentiation of the IMMATURE B-LYMPHOCYTES. B-Cell Heavy Chain Gene Rearrangement,B-Lymphocyte Heavy Chain Gene Rearrangement,B-Lymphocyte Mu Chain Gene Rearrangement,B Cell Heavy Chain Gene Rearrangement,B Cell Mu Chain Gene Rearrangement,B Lymphocyte Heavy Chain Gene Rearrangement,B Lymphocyte Mu Chain Gene Rearrangement

Related Publications

N Renard, and V Duvert, and D J Matthews, and M P Pagés, and J P Magaud, and A M Manel, and D Pandrau-Garcia, and N Philippe, and J Banchereau, and S Saeland
April 1993, Leukemia,
N Renard, and V Duvert, and D J Matthews, and M P Pagés, and J P Magaud, and A M Manel, and D Pandrau-Garcia, and N Philippe, and J Banchereau, and S Saeland
August 1982, Gan,
N Renard, and V Duvert, and D J Matthews, and M P Pagés, and J P Magaud, and A M Manel, and D Pandrau-Garcia, and N Philippe, and J Banchereau, and S Saeland
September 2018, Blood advances,
N Renard, and V Duvert, and D J Matthews, and M P Pagés, and J P Magaud, and A M Manel, and D Pandrau-Garcia, and N Philippe, and J Banchereau, and S Saeland
April 2010, Cytokine,
N Renard, and V Duvert, and D J Matthews, and M P Pagés, and J P Magaud, and A M Manel, and D Pandrau-Garcia, and N Philippe, and J Banchereau, and S Saeland
January 1991, Leukemia & lymphoma,
N Renard, and V Duvert, and D J Matthews, and M P Pagés, and J P Magaud, and A M Manel, and D Pandrau-Garcia, and N Philippe, and J Banchereau, and S Saeland
April 1991, Leukemia,
N Renard, and V Duvert, and D J Matthews, and M P Pagés, and J P Magaud, and A M Manel, and D Pandrau-Garcia, and N Philippe, and J Banchereau, and S Saeland
March 2018, EMBO reports,
N Renard, and V Duvert, and D J Matthews, and M P Pagés, and J P Magaud, and A M Manel, and D Pandrau-Garcia, and N Philippe, and J Banchereau, and S Saeland
June 1990, Blood,
N Renard, and V Duvert, and D J Matthews, and M P Pagés, and J P Magaud, and A M Manel, and D Pandrau-Garcia, and N Philippe, and J Banchereau, and S Saeland
August 1990, Leukemia,
N Renard, and V Duvert, and D J Matthews, and M P Pagés, and J P Magaud, and A M Manel, and D Pandrau-Garcia, and N Philippe, and J Banchereau, and S Saeland
January 2003, Cancer genetics and cytogenetics,
Copied contents to your clipboard!